State Street Corporation 13D and 13G filings for Celldex Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-12 10:18 am Sale | 2026-03-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | STATE STREET CORPORATION STT | 2,804,168 4.200% | -593,545 (-17.47%) | Filing |
| 2026-02-09 06:26 am Purchase | 2025-12-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | STATE STREET CORPORATION STT | 3,397,713 5.100% | 1,106,259 (+48.28%) | Filing |
| 2023-02-01 10:22 am Sale | 2022-12-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | STATE STREET CORPORATION STT | 2,291,454 4.870% | -76,586 (-3.23%) | Filing |
| 2022-02-10 1:29 pm Purchase | 2021-12-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | STATE STREET CORPORATION STT | 2,368,040 5.070% | 2,079,862 (+721.73%) | Filing |